Kangji Medical's (HKG:9997) associate, Hangzhou Weijing Medical Robot, obtained regulatory approval from China's National Medical Products Administration for its proprietary four-arm laparoscopic surgical robot, a Tuesday Hong Kong bourse filing said.
The clearance covers clinical applications in urological, gynecological, and general surgical laparoscopic procedures.
Surgical device maker Kangji Medical directly holds around 41.99% equity interest in Hangzhou Weijing Medical Robot.